RE:It's Time for New ManagementTo me , the question is here is what has management been doing all year? Maybe that should include all the time since April 25,2022 when Beedie Capital stepped up? Why are revenues and costs continuing to be out of whack?
"Operating expenses declined to $13.9 million in Q3 and $42.1 million in the year-to-date 2023 representing a decrease of 1% and 5% over the prior year periods."
Supposedly the focus has been on operational rationalization . The results so have the closure of a clinic , St. Louis which was closed in late September which should produce $2 million dollars of savings relatively quickly as Missouri is a "Right to Work" with no severance costs and another clinic was sold and immaterial to results.
It just seems like watching a little leak erode the dam and then when it gets big hurriedly hauling a dump truck to the leak. This is reactive management , not proactive management.
Interesting tidbit from the conference call when the Desjardins analyst was the best . Pharmapod has very limited competition in the market place ...... part of a fire sale?